|
Ca2+/CaM-Dependent Protein Kinase II: A Novel Target in Osteosarcoma
|
1R43CA159562-01A1
|
$279,182
|
$279,182
|
Schulman, Howard
|
ALLOSTEROS THERAPEUTICS, INC.
|
|
Development of transporter targeted platinum drugs for neuroblastoma
|
1R43CA174132-01
|
$172,738
|
$172,738
|
Mamelok, Richard
|
APRICITY THERAPEUTICS, INC.
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$82,648
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying B
|
5R01CA154489-02
|
$326,398
|
$326,398
|
ALLEN, CARL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving T-cell therapies for neuroblastoma
|
5R01CA142636-03
|
$377,399
|
$377,399
|
DOTTI, GIANPIETRO
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
5R01CA137019-03
|
$291,218
|
$145,609
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk
|
1K23CA158148-01A1
|
$169,983
|
$169,983
|
Gramatges, Maria
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
2P50CA126752-06
|
$2,300,000
|
$253,000
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Neurocognitive Outcomes Following Proton Beam Radiation Therapy for Treatment of
|
5K07CA157923-02
|
$148,700
|
$148,700
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Localization and Function of NKT Cells in Neuroblastoma
|
5R01CA116548-07
|
$234,457
|
$234,457
|
METELITSA, LEONID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$4,558
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$8,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$322,823
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genomic Approaches to Defining Inherited Basis of Childhood Cancer
|
5R01CA138836-03
|
$433,740
|
$433,740
|
PLON, SHARON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Clinical Research Training Program
|
2K12CA090433-11
|
$742,728
|
$742,728
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors
|
5R01CA132899-04
|
$335,446
|
$335,446
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
Chimeric T Cell for Therpay of Hodgkin Disease
|
5R01CA131027-05
|
$308,958
|
$308,958
|
SAVOLDO, BARBARA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Training Program in Pediatric Cancer Epidemiology and Control
|
5R25CA160078-02
|
$387,302
|
$387,302
|
SPITZ, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-09
|
$2,300,000
|
$276,000
|
McDermott, David
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Dissecting sarcoma complexity via innovative microRNA and informatics approaches
|
5K22CA138716-03
|
$191,160
|
$95,580
|
Spentzos, Dimitrios
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
3R01CA079830-11S1
|
$22,311
|
$22,311
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
5R01CA079830-11
|
$320,196
|
$320,196
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
4R00CA134743-03
|
$233,147
|
$46,629
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
$13,707
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
$20,295
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-31
|
$7,759,618
|
$931,154
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
$114,310
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation
|
2R01CA047006-25
|
$565,231
|
$282,616
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus LMP1-Mediated Oncogenecity
|
2R01CA085180-11A1
|
$701,405
|
$350,703
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-03
|
$131,854
|
$1,319
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Suv39H Targeted Therapy for Treatment of Childhood Rhabdomyosarcoma
|
1R41CA150437-01A1
|
$100,000
|
$100,000
|
MAL, ASOKE
|
BUFFALO BIOLABS, LLC
|
|
Using mouse models to understand retinoblastoma initiation and progression
|
5R01CA148867-03
|
$205,248
|
$205,248
|
MacPherson, David
|
CARNEGIE INSTITUTION OF WASHINGTON, D.C.
|
|
Pax5:Hematopoietic Transcription Factor Involved in ALL
|
5R01CA026038-33
|
$365,285
|
$365,285
|
Koeffler, H.
|
CEDARS-SINAI MEDICAL CENTER
|
|
Molecular pathogenesis of MLL-AF4 leukemias
|
5R01CA140575-03
|
$350,219
|
$350,219
|
ARMSTRONG, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
7K08CA133103-05
|
$140,940
|
$140,940
|
Gutierrez, Alejandro
|
CHILDREN'S HOSPITAL BOSTON
|
|
The role of Hedgehog in hematopoiesis and leukemogenesis
|
5K08CA140723-03
|
$164,250
|
$82,125
|
Hofmann Zhang, Inga
|
CHILDREN'S HOSPITAL BOSTON
|
|
Epigenetic Regulation of Medulloblastoma
|
5R01CA135454-04
|
$350,219
|
$350,219
|
JACKSON-GRUSBY, LAURIE
|
CHILDREN'S HOSPITAL BOSTON
|
|
Genomic Analysis of Medulloblastomas
|
5R01CA109467-07
|
$758,783
|
$758,783
|
POMEROY, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-08
|
$325,549
|
$162,775
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Cancer Biology in the Zebrafish
|
5R01CA103846-10
|
$366,757
|
$183,379
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL BOSTON
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
3R01CA129377-05S1
|
$90,845
|
$90,845
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
5R01CA129377-05
|
$232,601
|
$232,601
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Training of Physician Scientists in Cancer Research
|
5T32CA009659-18
|
$133,636
|
$133,636
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-02
|
$573,087
|
$573,087
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Investigating the Role of Adipocytes on Leukemia Relapse
|
5R01CA139060-04
|
$322,443
|
$322,443
|
Mittelman, Steven
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
|
5R01CA139032-04
|
$322,040
|
$161,020
|
Muschen, Markus
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Infectious origins of childhood leukemia
|
5R01CA157644-02
|
$332,000
|
$332,000
|
Muschen, Markus
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-13
|
$2,006,380
|
$2,006,380
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Gene Expression of Neuroblastoma and Normal Cells in Bone Marrow Predicts Outcome
|
5R33CA152809-03
|
$426,711
|
$426,711
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Amplifying Radiation Potency Against Leukemic Stem Cells
|
1R21CA164098-01
|
$211,410
|
$211,410
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL LOS ANGELES
|
Total relevant funding to Childhood Cancers for this search: $208,070,156
|